Updated Jul 16, 2026
Mancini Anthony has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.19M.
Anthony Mancini is an executive associated with Revolution Medicines, Inc., a biotechnology company focused on developing targeted therapies for cancer treatment. His role within the company involves strategic decision-making and oversight of operations.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 4.6K | $156.12 | $720K |
| 2026-05-28 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 421 | $154.82 | $65K |
| 2026-05-28 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 2.0K | $154.06 | $308K |
| 2026-05-28 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 700 | $153.30 | $107K |
| 2026-05-28 | RVMD | Revolution Medicines, Inc. | M — Option exercise | 3.1K | $33.62 | $105K |
| 2026-04-29 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 400 | $134.34 | $54K |
| 2026-04-29 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 1.0K | $132.88 | $139K |
| 2026-04-29 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 1.7K | $131.66 | $220K |
| 2026-04-29 | RVMD | Revolution Medicines, Inc. | M — Option exercise | 3.1K | $33.62 | $105K |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 400 | $97.21 | $39K |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 11.0K | $96.43 | $1.06M |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 21.1K | $95.49 | $2.01M |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 3.1K | $94.16 | $295K |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 1.8K | $93.22 | $168K |
| 2026-03-27 | RVMD | Revolution Medicines, Inc. | M — Option exercise [10b5-1] | 37.5K | $33.62 | $1.26M |
Anthony Mancini is an executive associated with Revolution Medicines, Inc., a biotechnology company focused on developing targeted therapies for cancer treatment. His role within the company involves strategic decision-making and oversight of operations.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($5.19M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mancini Anthony profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.